Related Experiment Videos
Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report
P P Kumar1, F P Ogren, R D McComb
1Division of Radiation Oncology, University of Nebraska Medical Center, Omaha 68105-1065.
Journal of the National Medical Association
|August 1, 1991
Abstract:
A 67-year-old woman presented with an advanced esthesioneuroblastoma that recurred 2 years following external irradiation. She was successfully retreated with continuous low-dose rate interstitial irradiation from high-activity I-125 seeds implanted permanently into the tumor.